Zohydro was approved over the advice of an FDA panel.
Medical Devices and Prescription Drug Policy
He is working with several other senators on a bill that would target the FDA's approval process, after the agency gave the green light in October to Zohydro, which critics say is a highly-addictive and easily-abused painkiller.
The Federal Communications Commission wants to help healthcare organizations adopt the latest technology and the fastest broadband Internet.
Sen. Chuck Schumer (D-NY.) called on the Department of Health and Human Services (HHS) to overturn a Food and Drug Administration (FDA) decision to allow a powerful painkiller to enter the market in a form that can be abused.
“It is baffling that at the same time policy makers and law enforcement officials are waging a war on the growing prescription drug crisis, we are essentially rolling out the welcome mat to a new, more powerful, and easily abused super-drug,” Schumer said Monday.
The backlash continues to grow over what critics say is a highly addictive prescription drug.
The price of generic drugs would skyrocket, according to a new report.
Pharmaceutical companies are expressing growing concerns about a trend in Canadian courts where patents on medicines are being revoked over challenges of their usefulness.
Since 2005, Canadian courts have made 21 decisions denying patent utility to 18 products made by 10 companies, allowing Canadian companies to manufacture the drugs before the end of the 20-year patents, according to a document obtained by The Hill.
Two members of the House have introduced legislation that would limit the sale of certain over-the-counter cough medicines to people 18 and older, an effort to limit access to an ingredient in these medicines that some kids are using to get high.
The lenses would measure blood sugar levels for people with diabetes.
They were not amused to see "Veep" star Julia Louis-Dreyfus puffing on an e-cigarette.